Pacira BioSciences News

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswireSep 10 04:00

Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma

Seeking AlphaSep 6 20:39 · Ratings

Lacklustre Performance Is Driving Pacira BioSciences, Inc.'s (NASDAQ:PCRX) 26% Price Drop

Simply Wall StAug 30 19:55

Pacira BioSciences Analyst Ratings

BenzingaAug 13 21:59 · Ratings

Express News | Pacira Biosciences Inc : Truist Securities Cuts Target Price to $8 From $30

BreakingsAug 13 19:02

Express News | Pacira Biosciences Inc : Truist Securities Cuts to Sell From Buy

BreakingsAug 13 19:02

Truist Financial Downgrades Pacira BioSciences(PCRX.US) to Sell Rating, Announces Target Price $8

Truist Financial analyst Les Sulewski downgrades $Pacira BioSciences(PCRX.US)$ to a sell rating, and sets the target price at $8.According to TipRanks data, the analyst has a success rate of 41.2%

Futu NewsAug 13 18:31 · Ratings

Truist Securities Downgrades Pacira BioSciences to Sell From Buy, Adjusts Price Target to $8 From $30

MT NewswiresAug 13 18:25 · Ratings

Barclays Maintains Pacira BioSciences(PCRX.US) With Hold Rating, Maintains Target Price $25

Barclays analyst Balaji Prasad maintains $Pacira BioSciences(PCRX.US)$ with a hold rating, and maintains the target price at $25.According to TipRanks data, the analyst has a success rate of 44.9%

Futu NewsAug 13 17:33 · Ratings

Pacira Pharmaceuticals (PCRX) Gets a Hold From Barclays

TipRanksAug 13 16:47 · Ratings

Pacira Downgraded by J.P. Morgan, Piper, RBC, Raymond James

Seeking AlphaAug 13 03:27 · Ratings

Where Pacira BioSciences Stands With Analysts

BenzingaAug 13 02:00

Pacira (PCRX) Plummets as US Court Deems Exparel Patent Invalid

Zacks Aug 12 22:05

Sector Update: Health Care Stocks Flat to Higher Pre-bell Monday

MT NewswiresAug 12 21:10

JetBlue Airways, B. Riley Financial, Hawaiian Electric And Other Big Stocks Moving Lower In Monday's Pre-Market Session

BenzingaAug 12 20:20

Pacira BioSciences Lacks Near-Term Recovery Path After Patent Ruling -- Market Talk

WSJAug 12 19:59

Pacira BioSciences Is Maintained at Buy by HC Wainwright & Co.

Dow JonesAug 12 19:49

Truist Financial Sticks to Its Buy Rating for Pacira Pharmaceuticals (PCRX)

TipRanksAug 12 19:28

Express News | Pacira Biosciences Inc : RBC Cuts to Sector Perform From Outperform

BreakingsAug 12 19:26

Express News | Pacira Biosciences Inc : Needham Cuts Target Price to $22 From $43

BreakingsAug 12 19:19